LACONEXT INJECTION Substitute
Composition:
LACOSAMIDE-10MG
Uses:
Treatment of Focal or partial seizures
Medicinal Benefits:
LACONEXT INJECTION is an antiepileptic drug, also called anticonvulsants. It treats focal seizures in adults and children above one month of age. Seizures occur due to abnormal electrical activity in the brain. LACONEXT INJECTION can inactivate the sodium channels across the neuron membranes. This inactivation decreases neuron signals, thereby decreasing the brain's electrical disturbance or abnormal activity. It can also be used with other medications to manage primary generalized tonic-clonic seizures (Previously known as a grand mal seizure, a seizure affecting the entire body) in adults and children above 4 years of age who cannot take oral medications.
LACONEXT INJECTION belongs to the class of anticonvulsants used to treat partial onset seizures (seizures that affect only one portion of the brain) in adults and children one month or older who cannot take oral treatments. LACONEXT INJECTION is also used in conjunction with other medications to manage primary generalized tonic-clonic seizures.
LACONEXT INJECTION contains lacosamide, which treats seizures by decreasing disorganized electrical activity in the brain.
Coordination and walking issues normally improve within a few weeks. Inform your service provider if the problems persist.
LACONEXT INJECTION should be used with caution in patients who are taking drugs that influence cardiac conduction, such as sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers, and medications that lengthen the PR interval.
Your doctor can identify a seizure after hearing about your experience or the signs noted by others. Your doctor may recommend testing based on your symptoms and medical history. Brain imaging scans, blood tests, or a spinal tap may be used to determine the cause of your seizures.
In people with cardiac rhythm and conduction abnormalities, use LACONEXT INJECTION with caution. In patients with underlying proarrhythmic disorders or who are taking concomitant drugs that influence cardiac conduction, an ECG should be obtained before and after titration for steady-state maintenance; these patients should be regularly monitored.